Report Package: Hot Targets For Empowered Antibody And Cell Therapy Technologies

Report Package: Hot targets for empowered antibody and cell therapy technologies
This package contains three reports analyzing

BCMA,
CD123 and
CD22

as versatile and hot targets for the successful application of empowered antibody and cell technologies, including:

Fc-Engineered Antibodies;
Radioimmunotherapy;
Immunotoxins;
Antibody-Drug Conjugates;
T-Cell Redirecting Bispecific Antibodies;
Chimeric Antigen Receptor (CAR) T-Cells.

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/895855

The reports describe and discuss

Target background, scientific rationale & expression profiles;
Preclinical proof-of-concept;
Clinical experience;
Competitive landscape;
Drug or cell therapy profiles;
Company profiles.

Each of the three reports can be obtained individually, but the package of the three reports provides a 40% discount on the regular prices:
B-Cell Maturation Antigen (BCMA): hot target for emerging treatment modalities
CD123: a paradigmatic target for immunotherapeutic treatment modalities
CD22: a suitable antigen for targeted payload delivery by immunotherapeutics
Detailed report descriptions, tables of contents and samples from the reports can be found on the respective product page.

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.